Showing 1 - 4 results of 4 for search 'Glaciano Ribeiro', query time: 0.03s Refine Results
  1. 1
    PB2095: ELOTUZUMAB OR DARATUMUMAB IN COMBINATION WITH POMALIDOMIDE AND DEXAMETHASONE (EPD AND DPD) IN RELAPSED REFRACTORY MULTIPLE MYELOMA (RRMM): A NETWORK META-ANALYSIS

    PB2095: ELOTUZUMAB OR DARATUMUMAB IN COMBINATION WITH POMALIDOMIDE AND DEXAMETHASONE (EPD AND DPD) IN RELAPSED REFRACTORY MULTIPLE MYELOMA (RRMM): A NETWORK META-ANALYSIS by Tassia Cristina Decimoni, Adriana Cury, James Farrell, Nicolas Bertin, Claire Fischer, Victor Genestier, Jorge Vaz Pinto Neto, Glaciano Ribeiro, Angelo Maiolino

    Published 2023-08-01
    Get full text
    Article
  2. 2
    UPSHOTS IN ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA: ANALYSIS OF T-CELL BRAZIL PROJECT

    UPSHOTS IN ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA: ANALYSIS OF T-CELL BRAZIL PROJECT by Carlos CHIATTONE, Eliana MIRANDA, Guilherme DUFFLES, Marcia DELAMAIN, Juliana PEREIRA, Natalia ZING, Danielle FARIAS, Marcelo BELLESSO, Nelson CASTRO, Renata BAPTISTA, Karin CECYN, Suellen MO, Yana RABELO, Patricia RADTKE, Sergio BRASIL, Samir NABHAN, Glaciano RIBEIRO, Joao SOUTO-FILHO, Vera FIGUEIREDO, Rony SCHAFFEL, Maria DIAS, Elizete NEGREIROS, Eduardo RIBEIRO, Massimo FEDERICO, Carmino SOUZA

    Published 2021-11-01
    Get full text
    Article
  3. 3
    Lower access to risk stratification tests and drugs, and worse survival of chronic lymphocytic leukaemia patients treated in public as compared to private hospitals in Brazil: A retrospective analysis of the Brazilian registry of chronic lymphocytic leukaemia

    Lower access to risk stratification tests and drugs, and worse survival of chronic lymphocytic leukaemia patients treated in public as compared to private hospitals in Brazil: A re... by Verena Pfister, Fernanda de Morais Marques, Flavia Parra, Mihoko Yamamoto, Matheus Vescovi Gonçalves, Leila Perobelli, Valeria Buccheri, Raphael Bandeira, Sergio Fortier, Alita Azevedo, Rodrigo Santucci, Marcelo Bellesso, Laura Fogliatto, Glaciano Ribeiro, Germison Silva Lopes, Maura Ikoma, Vera P. Figueiredo, Irene Gyongyver H Lorand Metze, Carlos Sérgio Chiattone, Celso Arrais‐Rodrigues

    Published 2022-08-01
    Get full text
    Article
  4. 4
    Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma, eligible for transplantation

    Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed mult... by Edvan De Queiroz Crusoe, Fabiana Higashi, Gracia Martinez, Rosane Bittencourt, Jorge Vaz Pinto Neto, Lais Sousa, Rodrigo Santucci, Roberto José Pessoa Magalhães, Gilberto Colli, Renata Ferreira Marques Nunes, Glaciano Ribeiro, Jandir Nicacio, Karla Richter Zanella, Jose Mauro Kutner, Andre Magalhaes, Danielle Leao, Abrahão Elias Hallack Neto, Walter Braga, Emanuella G Souza, Antonio Julio A.M. Guimaraes, Giovanna Steffenello Durigon, Dani Laks, Angelo Maiolino, Vania Tietsche de Moraes Hungria

    Published 2020-04-01
    Get full text
    Article

Search Tools: